Fundz

Opti Nose, Inc. reported raising $4 Million in an initial SEC Form D filing, from an offering of $4 Million

PRIVATENov 30, 2021

Amount Raised

$4 Million

$4 Million sold, per SEC Form D (first sale Nov 30, 2021)

Round Type

Seed

YardleyHealthcare

Who to call at Optinose, and when

A new round usually means Optinose is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Optinose raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Optinose, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Optinose. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Optinose

Location

1020 STONY HILL ROAD

Yardley, Pennsylvania, United States

About

Optinose is a biopharmaceutical company specializing in the development of unique therapeutics for patients with ear, nose, and throat conditions. The company's leading product, XHANCE, is designed for the treatment of chronic rhinosinusitis. Optinose is dedicated to addressing unmet medical needs through its innovative approaches. The focus is on expanding treatment options for patients suffering from CRS.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Optinose raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Verified contactsRamy M., Executive Officer hiddenSee plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for Optinose's next move

See what Strategic adds

Optinose raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.